University of Texas Health Science Center at Tyler Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 58
• Lung Cancer Treatments and Mutations 37
• Cancer Immunotherapy and Biomarkers 27
• Head and Neck Cancer Studies 18
• Hepatocellular Carcinoma Treatment and Prognosis 17
• Multiple Myeloma Research and Treatments 16
• Chronic Myeloid Leukemia Treatments 14
• Hematopoietic Stem Cell Transplantation 14
• Immunotherapy and Immune Responses 13
• Colorectal Cancer Treatments and Studies 10
• Growth Hormone and Insulin-like Growth Factors 9
• Lung Cancer Diagnosis and Treatment 9

Most cited

1. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Erminia Massarelli

2. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Erminia Massarelli

3. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Erminia Massarelli

4. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Erminia Massarelli

5. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.

   The New England journal of medicine · 2023 · 280 citations · Erminia Massarelli

6. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.

   Cancer cell · 2022 · 343 citations · Ronan Swords